Sinopharm - Asia Tech Wire

Sinopharm

2022.04.26

06:44

Omicron-specific Sinopharm COVID-19 vaccine approved for clinical trials in China

Asian Tech Press (Apr. 26) -- Sinopharm's COVID-19 vaccine candidate against Omicron variant got approval for clinical trials in China.

2021.11.09

07:14

UK adds Sinovac, Sinopharm Beijing, Covaxin vaccines to approved travel list

Asian Tech Press (Nov 09) -- The UK government has announced that it will recognize the World Health Organization's (WHO) Covid-19 Vaccine Emergency Use List, including China's Sinopharm and Sinovac vaccines and India's Covaxin, from November 22. Travelers who have been fully vaccinated with the vaccines on the list do not need to be quarantined when they arrive in the UK.

2021.09.13

07:42

Myanmar receives 4 million doses of China's Sinopharm COVID-19 vaccine

Asian Tech Press (Sep 13) -- The Myanmar government received 4 million doses of COVID-19 vaccine purchased from Chinese state-owned drugmaker Sinopharm Group Co. Ltd. on Sunday.

2021.09.10

08:26

Serbia starts building first plant to produce Chinese Sinopharm COVID-19 vaccine

Asian Tech Press (Sep 10) -- Serbia started building Europe's first plant to produce China's Sinopharm COVID-19 vaccine, President Aleksandar Vučić announced Thursday.

2021.08.26

06:21

Nigeria approves China's Sinopharm COVID-19 vaccine for emergency use

Asian Tech Press (Aug 26) -- A Nigerian health official said Tuesday local time that Nigerian regulators have approved China's Sinopharm COVID-19 vaccinene for emergency use in the country.

2021.08.17

08:26

Argentina finds China's Sinopharm COVID vaccine 84% effective in preventing death

The Argentine Ministry of Health has released a report announcing data on the incidence of adverse reactions to China's Sinopharm Covid-19 vaccine in Argentina and the vaccine's effectiveness in preventing death in people aged over 60.

2021.08.06

07:59

Sinovac to file for EUA for its COVID-19 vaccine against Delta variant in countries

Asian Tech Press -- Yin Weidong, chairman and CEO of Sinovac Biotech Ltd (SVA: NASDAQ GS), said in a speech at the first International Forum on Vaccine Cooperation on August 5, that Sinovac will soon submit applications to national drug regulatory authorities in several countries for clinical studies and Emergency Use Authorization (EUA) of its COVID-19 vaccines against Gamma and Delta variants.

2021.07.27

10:06

Chinese inactivated Covid-19 vaccine receives $10M support from CEPI

According to China National Biotec Group Company Limited (CNBG), with the support of Coalition for Epidemic Preparedness Innovations (CEPI), the International Vaccine Institute (IVI) and Sinopharm China Biologicals have launched a collaborative "ECOVA" project to conduct a Phase III clinical trial of the BBIBP-CorV Covid-19 inactivated vaccine developed by the Beijing Institute of Biological Products.

2021.05.28

12:00

Thailand approves China's Sinopharm vaccine for emergency use

2021.05.27

04:13

Phase III trial results of China's inactivated Covid-19 vaccines officially published

According to Sinopharm, on May 26th, The Journal of the American Medical Association (JAMA, IF45.54) published an article by Sinopharm's China National Biotec Group Company Limited (CNBG) on "Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults".

2021.05.21

04:00

Indonesia increases import of Chinese COVID-19 vaccine

Sinopharm vaccine

2021.05.19

04:16

President of North Macedonia gets China's Sinopharm COVID-19 shot

On Tuesday, April 18, local time, the President of North Macedonia, Stevo Pendarovski got a COVID-19 shot developed by Chinese state-owned drugmaker Sinopharm Group Co. Ltd. at a vaccination site in the city of Kumanovo.

2021.05.10

12:30

GAVI in talks with COVID-19 vaccine makers including China's Sinopharm for COVAX doses

Gavi, the Vaccine Alliance, says it is in talks with COVID-19 vaccine manufacturers including Chinese state-owned drugmaker Sinopharm Group Co. Ltd., to expand the pipeline of the worldwide initiative COVID-19 Vaccines Global Access (COVAX) and secure doses for distribution, according to Reuters reported on Monday.

2021.04.10

11:27

126 COVID-19 cases in the Philippine Presidential Security Group, some members had used China's vaccines

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tesla's (TSLA.O) shares fell as much as 5% in pre-market trading after its fourth-quarter deliveries fell short of expectations.
                            2025-01-02

                                    Tesla (TSLA.O) produced 22,727 other models in the fourth quarter, compared with market forecasts of 22,790.
                            2025-01-02

                                    Yunding Technology: The company currently has no self-owned AI hardware products for sale
                            2025-01-02

                                    Tesla (TSLA.O) Model 3/Y production in the fourth quarter of 2024 was 436,718 units.
                            2025-01-02

                                    Tesla (TSLA.O) shares fell 2.7% in pre-market trading.
                            2025-01-02